首页> 外文期刊>The journal of alternative and complementary medicine: research on paradigm, practice, and policy >A prospective, randomized, controlled study to evaluate the efficacy and tolerability of Ayurvedic formulation 'varuna and banana stem' in the management of urinary stones.
【24h】

A prospective, randomized, controlled study to evaluate the efficacy and tolerability of Ayurvedic formulation 'varuna and banana stem' in the management of urinary stones.

机译:一项前瞻性,随机对照研究,旨在评估阿育吠陀制剂“内脏和香蕉茎”在治疗尿路结石中的功效和耐受性。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Medical management of urinary calculus disease is a challange for modern science. In the present trial Ayurvedic drug "Herbmed," which is made up of varuna (Crataeva nurvala) and banana stem (Musa paradisiaca) was assessed to see reduction and/or expulsion of urinary calculi and also to assess the role of these drugs to reduce pain during expulsion. MATERIALS AND METHODS: In this prospective randomized, double-blind, placebo control trial, total 77 patients with calculi more than 5 mm were included. All patients were evaluated either by X-ray KUB or USG KUB for 3 months. All patients were divided into two groups: group A included patients with calculi 5-10 mm (n = 31) and group B with calculi > 10 mm (n = 30) with either active treatment or placebo in both the groups. All patients were asked to keep a record of number of pain episodes, while severity of pain was measured on a visual analogue scale (VAS). RESULTS: In group A, there was 33.04% reduction in the size of calculi in the active arm while there was a 5.13% increase in the same group in the placebo arm (p = 0.017). In the other group B, there was an 11.25% reduction in the active arm and a 1.41% reduction in the same group with placebo. In the active arm there was statistically significant lower VAS as compared to the placebo arm in the form of the highest VAS (p = 0.008), average VAS (p = 0.001) and VAS at the first episode of pain (p < 0.0001). CONCLUSIONS: Our preliminary experience suggests that the Ayurvedic formulation "varuna and banana stem" has promise for the management of upper urinary-tract calculi, especially renal calculi. It helps to dissolve renal calculi and facilitate their passage. In addition, it also helps in reduction of pain due to renal/ureteric calculus disease. A larger phase III study with a longer follow-up is required.
机译:背景:泌尿系结石疾病的医疗管理是现代科学的一个挑战。在本试验中,对由阿鲁吠陀(Crataeva nurvala)和香蕉茎(Musa paradisiaca)组成的阿育吠陀药物“ Herbmed”进行了评估,以观察尿结石的减少和/或排出,并评估这些药物在减少尿路结石中的作用驱逐期间疼痛。材料与方法:在这项前瞻性随机,双盲,安慰剂对照试验中,纳入了77例结石超过5毫米的患者。所有患者均接受X射线KUB或USG KUB评估3个月。所有患者均分为两组:A组包括结石5-10 mm(n = 31),B组结石> 10 mm(n = 30)接受主动治疗或安慰剂治疗。要求所有患者记录疼痛发作的次数,同时以视觉模拟量表(VAS)测量疼痛的严重程度。结果:在A组中,活动组的结石大小减少了33.04%,而在安慰剂组中,同一组的结石大小增加了5.13%(p = 0.017)。在另一组B中,使用安慰剂的同一组的活动臂下降了11.25%,而同一组下降了1.41%。在活动组中,与安慰剂组相比,VAS具有最高的VAS(p = 0.008),平均VAS(p = 0.001)和第一次疼痛发作时的VAS(p <0.0001),具有统计学上的显着性降低。结论:我们的初步经验表明,阿育吠陀制剂“内翻和香蕉茎”有望治疗上尿路结石,尤其是肾结石。它有助于溶解肾结石并促进其通过。另外,它还有助于减轻由于肾/输尿管结石疾病引起的疼痛。需要进行较大的III期研究,并进行更长的随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号